Location History:
- Santa Barbara, CA (US) (1985)
- Carpinteria, CA (US) (1986)
- Carpenteria, CA (US) (1992 - 1998)
Company Filing History:
10 out of 22 
3 out of 832,812 Years Active: 1985-1998
Title: John H Calvin: Innovator in Cardiac Valve Technology
Introduction:
In the realm of cardiac valve technology, John H Calvin has made a significant impact with a series of groundbreaking inventions. Hailing from Carpenteria, California, Calvin has accumulated an impressive portfolio of 13 patents, showcasing his expertise and dedication to improving the field of heart valve treatments. This article delves into Calvin's latest patents, highlights milestones in his career, explores his collaborations, and recognizing his invaluable contributions.
Latest Patents:
Calvin's latest patents showcase his remarkable ingenuity and vision for improving heart valve treatments. One notable invention is the "Stents for Autologous Tissue Heart Valve." This cutting-edge set of stents, designed with the help of computer-aided design technology, ensures secure clamping of a piece of tissue forming the heart valve leaflets. The stents boast carefully planned geometrical features that prevent the formation of stress raisers and minimize complications during valve implantation. Moreover, Calvin's design incorporates narrower windows in the stent posts to prevent needle entanglement and ensures better bond stability with the patient's blood flow.
Another groundbreaking invention by Calvin is the "Test Device for and Method of Testing Rapid Assembly Tissue Heart Valve." This method enables the precise cutting of autologous tissue, followed by the creation of holes that align with tissue alignment members in the stents. By clamping the tissue securely between the stents, a constructed tissue heart valve is created. This valve undergoes meticulous testing in a dedicated chamber to detect any potential leaks, ensuring its reliability and efficacy during open-heart surgery.
Career Highlights:
Throughout his illustrious career, Calvin has contributed significantly to the field of cardiac valve technology. His innovative ideas and patents have not only revolutionized heart valve treatments but also inspired further advancements in the industry. Working with companies like Autogenics and others, Calvin has consistently demonstrated his commitment to pushing the boundaries of medical science.
Collaborations:
Collaboration has been vital to Calvin's success. In his journey, he has had the privilege of working alongside esteemed colleagues such as Charles S Love and Jack W Love. These collaborations have allowed Calvin to tap into their collective expertise, exchange ideas, and refine his inventions. Through these synergistic partnerships, Calvin has been able to create truly groundbreaking solutions within the field of cardiac valve technology.
Conclusion:
John H Calvin's contributions to cardiac valve technology have left an indelible mark on the medical field. His latest patents, including the innovative stents for autologous tissue heart valves and the test device for rapid assembly tissue heart valves, demonstrate his unwavering commitment to advancing heart valve treatments. Calvin's collaborations with esteemed colleagues Charles S Love and Jack W Love have further enhanced the impact of his inventions. As Calvin continues his journey as an inventor and innovator, the medical community eagerly anticipates his future contributions to the field of cardiac care.